Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study
Purpose: To evaluate efficacy and safety of 20 000 IU cholecalciferol weekly in HIV-infected patients. Methods: Longitudinal data for 243 HIV-infected patients with paired 25-OH-vitamin D3 values for the same month in 2 consecutive years were stratified by the initiation of supplementation in this r...
Main Authors: | Sebastian Noe MD, Silke Heldwein MD, Rita Pascucchi MD, Celia Oldenbüttel MD, PhD, C. Wiese MD, Ariane von Krosigk MD, Eva Jägel-Guedes MD, Hans Jäger MD, Wolfgang Mayer MD, Christoph D. Spinner MD, Eva Wolf PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-07-01
|
Series: | Journal of the International Association of Providers of AIDS Care |
Online Access: | https://doi.org/10.1177/2325957417702487 |
Similar Items
-
Monthly or Weekly Supplementation with Cholecalciferol 20,000 IU in People Living with HIV: Results from a Nested Cohort Study
by: Sebastian Noe, et al.
Published: (2018-01-01) -
Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
by: Yuichiro Okumura, MD, et al.
Published: (2017-09-01) -
Hypothyroidism Could be a Potential Factor to Prolong Subcutaneous Nodules of Exenatide once Weekly: A Case Report
by: Ayako Ito, MD, et al.
Published: (2019-05-01) -
Results of a 5 Year, 10,000 Scans Experience with Weight-Bearing CT. Impact on Costs, Radiation Exposure and Time Spent
by: Martinus Richter MD, PhD, et al.
Published: (2019-10-01) -
Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies
by: Liesbeth Lenaerts, PhD, et al.
Published: (2021-05-01)